| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/14/2006 | EP1438076B1 Radiopharmaceutical agent for the treatment of early stage cancer |
| 06/14/2006 | CN1785435A Method of preparing ultrasonic contrast agent using mechanical oscillation |
| 06/14/2006 | CN1785434A Acute early young granulocytic leakemia transplantation mouse model of PLZF-RARa and PLZF-RARa/RARa-PLZF |
| 06/14/2006 | CN1785433A Preparation method of Type II diabetes animal model |
| 06/14/2006 | CN1785426A Method of inhibiting neonate tumour blood vessel |
| 06/13/2006 | USRE39132 Thiazoline acid derivatives |
| 06/13/2006 | US7062312 Combination and method including a visual marker for determining compliance with a medication regimen |
| 06/13/2006 | US7061237 Remote NMR/MRI detection of laser polarized gases |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060298 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/13/2006 | US7060275 targets brain tumor protein targets which allow for the selective inhibition of cell function or selective marking for visualization with therapeutic or visualizing compositions which have a specific affinity for these protein targets |
| 06/13/2006 | US7060251 Imaging agents for early detection and monitoring of cardiovascular plaque |
| 06/13/2006 | US7060250 Chelate compounds |
| 06/13/2006 | US7060249 Obtaining and identifying drosophila neurodegeneration mutant which demonstrates temperature-sensitive and bang-sensitive paralysis phenotypes; neuroprotectants |
| 06/13/2006 | US7060248 Chelate compounds; diagnosis of disease; detection of conjestive heart failurel |
| 06/13/2006 | US7060247 Metal complexed with chelating group attached to gastrin releasing peptide receptor agonist which includes a bombesin agonist binding moiety; for use as therapeutic or diagnostic radiopharmaceutical |
| 06/08/2006 | WO2006060797A2 Mri guided photodynamic therapy for cancer |
| 06/08/2006 | WO2006060393A2 Biological systems analysis |
| 06/08/2006 | WO2005120584A3 Radiolabeled arylsulfonyl compounds and uses thereof |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123498 Paks as modifiers of the chk pathway and methods of use |
| 06/08/2006 | US20060123487 Methods of screening agents for activity using teleosts |
| 06/08/2006 | US20060122503 Imageable biopsy site marker |
| 06/08/2006 | US20060121449 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121067 Menthol-containing preparation |
| 06/08/2006 | US20060120965 Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives |
| 06/08/2006 | US20060120964 Inorganic reaction product of metal oxides, metal sulfides |
| 06/08/2006 | US20060120963 Method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 06/08/2006 | US20060120962 Cardiac safe, rapid medication delivery |
| 06/08/2006 | US20060120961 Glycan analysis using deuterated glucose |
| 06/08/2006 | US20060120956 Imaging agents comprising barbituric acid derivatives |
| 06/08/2006 | DE20122582U1 Zubereitung für Restenoseprophylaxe Preparation for prophylaxis of restenosis |
| 06/08/2006 | CA2588759A1 Biological systems analysis |
| 06/08/2006 | CA2587507A1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 06/07/2006 | EP1666071A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1666070A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1664272A2 Targeting endothelium for tissue-specific delivery of agents |
| 06/07/2006 | EP1663281A2 Poly-pegylated protease inhibitors |
| 06/07/2006 | EP1663279A2 Modified protease inhibitors |
| 06/07/2006 | EP1663239A2 Potassium channel mediated delivery of agents through the blood-brain barrier |
| 06/07/2006 | EP1663138A2 Dye composition and method for detection of demineralized lesions in teeth |
| 06/07/2006 | EP1663109A2 Ultrasonic concentration of drug delivery capsules |
| 06/07/2006 | EP1663108A2 Echogenic coatings with overcoat |
| 06/07/2006 | EP1662995A1 Method for analyzing airway disorders |
| 06/07/2006 | EP1563067A4 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 06/07/2006 | EP1563066A4 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | CN1783363A Ferroferric oxide magnetic fluid and its preparing method and use |
| 06/06/2006 | US7057031 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 06/06/2006 | US7056689 Methods of treating and detecting cancer using viruses |
| 06/06/2006 | US7056506 Methods for detecting and inhibiting angiogenesis |
| 06/06/2006 | US7056493 Radio-opaque polymer biomaterials |
| 06/06/2006 | US7056492 Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle |
| 06/06/2006 | US7056491 Sensitizing tumor cells with terpene such as perillyl alcohol |
| 06/06/2006 | CA2171303C Active principles and gas containing microparticles |
| 06/01/2006 | WO2006057988A2 Use of endothelin etb receptor agonists and eta receptor antagonists in tumor imaging |
| 06/01/2006 | WO2006056227A1 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 06/01/2006 | WO2006017333A3 Shortened carbon nanotubes |
| 06/01/2006 | WO2006011811A3 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process |
| 06/01/2006 | WO2005101993A9 Metal-containing nanolayered composites, and applications thereof |
| 06/01/2006 | WO2005094327A3 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling |
| 06/01/2006 | WO2005084716A3 Phospholipid analogs for diagnosis and treatment of cancer |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060115895 Fish disease models and uses thereof |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115431 Procedures of cellular labelling with paramagnetic complexes for mri applications |
| 06/01/2006 | US20060115430 Calcium challenge test for detecting calcium homeostasis disorders |
| 06/01/2006 | US20060115429 Biological systems analysis |
| 05/31/2006 | EP1661557A1 Materials and methods for making improved micelle compositions |
| 05/31/2006 | EP1660884A2 Crown ether derivatives |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660519A2 Fluorinated carbohydrate conjugates |
| 05/31/2006 | EP1660110A2 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 05/31/2006 | EP1659938A2 Polymersomes incorporating highly emissive probes |
| 05/31/2006 | EP1659858A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | EP1207910B1 Composition comprising diagnostic agents in silica-coated containers |
| 05/31/2006 | EP1181939B1 Method for evaluating in vivo matrix metalloproteinase inhibitory activity |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP0885228B1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 05/31/2006 | CN1781019A Animal model simulating neurologic disease |
| 05/31/2006 | CN1778393A Evaluation of efficacy of medicine for moist wart |
| 05/31/2006 | CN1778280A Mouse asthmatic model semiotic monitor of acoustical sensor |
| 05/30/2006 | US7053263 Mouse models of human prostate cancer progression |
| 05/30/2006 | US7052677 Substituted octanuclear pyrazolato clusters with electron transfer and MRI contrast agent properties |
| 05/30/2006 | US7052676 Interference with binding chemokines |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | US7052673 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
| 05/30/2006 | CA2251924C Fluorescent chelates as visual tissue specific imaging agents |
| 05/26/2006 | WO2006055447A2 Nanoparticles having a magnetic core and a cationic organo-silane coating for the delivery of oligonucleotides |
| 05/26/2006 | WO2006054904A2 Contrast agents to target extracellular matrix |
| 05/26/2006 | WO2006054903A2 Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate |
| 05/26/2006 | WO2006053787A1 A non-human animal alzheimer’s disease model and uses thereof |
| 05/26/2006 | WO2006034005A3 Imaging reporters of transgene expression |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2005119251A3 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 05/26/2006 | WO2005112619A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/26/2006 | WO2005104836A3 Drosophila models for diseases affecting learning and memory |
| 05/26/2006 | WO2005094902A3 Nanoparticles comprising luminescent substances as contrast agent for optical imaging |